# Dixie Group Inc: overview DXYN · OTC · CIK 29332 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dxyn.md) · [Financials](/companies/dxyn/financials.md) · [Filings](/companies/dxyn/filings.md) · [Insiders](/companies/dxyn/insiders.md) Latest reported revenue: [$68.6m](/filings/0000029332-26-000045.md) for Q2 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000029332-26-000045). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [64.9](/filings/0000029332-25-000073.md) | [64.4 d](/filings/0000029332-26-000018.md) | [63.0](/filings/0000029332-26-000031.md) | [68.6](/filings/0000029332-26-000045.md) | [62.4](/filings/0000029332-25-000073.md) | [63.5 d](/filings/0000029332-26-000018.md) | [59.4](/filings/0000029332-26-000031.md) | [68.6](/filings/0000029332-26-000045.md) | | Gross margin | % | [24.6%](/filings/0000029332-25-000073.md) | [21.7% d](/filings/0000029332-26-000018.md) | [26.8%](/filings/0000029332-26-000031.md) | [29.2%](/filings/0000029332-26-000045.md) | [24.8%](/filings/0000029332-25-000073.md) | [27.0% d](/filings/0000029332-26-000018.md) | [32.5%](/filings/0000029332-26-000031.md) | [29.5%](/filings/0000029332-26-000045.md) | | Operating margin | % | [(3.2%)](/filings/0000029332-25-000073.md) | [(8.1%) d](/filings/0000029332-26-000018.md) | [0.0%](/filings/0000029332-26-000031.md) | [4.7%](/filings/0000029332-26-000045.md) | [(3.2%)](/filings/0000029332-25-000073.md) | [(1.7%) d](/filings/0000029332-26-000018.md) | [5.5%](/filings/0000029332-26-000031.md) | [4.5%](/filings/0000029332-26-000045.md) | | Net margin | % | [(6.0%)](/filings/0000029332-25-000073.md) | [(11.2%) d](/filings/0000029332-26-000018.md) | [(2.7%)](/filings/0000029332-26-000045.md) | [1.7%](/filings/0000029332-26-000045.md) | [(6.5%)](/filings/0000029332-25-000073.md) | [(4.7%) d](/filings/0000029332-26-000018.md) | [1.9%](/filings/0000029332-26-000045.md) | [1.6%](/filings/0000029332-26-000045.md) | | Diluted EPS | $ per share | [(0.27)](/filings/0000029332-25-000073.md) | not reported | [(0.12)](/filings/0000029332-26-000031.md) | [0.07](/filings/0000029332-26-000045.md) | [(0.29)](/filings/0000029332-25-000073.md) | not reported | [0.08](/filings/0000029332-26-000031.md) | [0.07](/filings/0000029332-26-000045.md) | | Free cash flow | $m | [1.3 d](/filings/0000029332-25-000073.md) | [3.9 d](/filings/0000029332-26-000018.md) | [7.5](/filings/0000029332-26-000031.md) | [1.1 d](/filings/0000029332-26-000045.md) | [0.8 d](/filings/0000029332-25-000073.md) | [(0.3) d](/filings/0000029332-26-000018.md) | [(2.6)](/filings/0000029332-26-000031.md) | [1.0 d](/filings/0000029332-26-000045.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-25) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [341](/filings/0000029332-23-000015.md) | [304](/filings/0000029332-24-000020.md) | [276](/filings/0000029332-25-000017.md) | [265](/filings/0000029332-26-000018.md) | [257](/filings/0000029332-26-000018.md) | | Gross margin | % | [22.6%](/filings/0000029332-23-000015.md) | [17.7%](/filings/0000029332-24-000020.md) | [26.7%](/filings/0000029332-25-000017.md) | [24.7%](/filings/0000029332-26-000018.md) | [27.0%](/filings/0000029332-26-000018.md) | | Operating margin | % | [2.9%](/filings/0000029332-23-000015.md) | [(9.3%)](/filings/0000029332-24-000020.md) | [1.8%](/filings/0000029332-25-000017.md) | [(2.2%)](/filings/0000029332-26-000018.md) | [0.0%](/filings/0000029332-26-000018.md) | | Net margin | % | [0.5%](/filings/0000029332-23-000015.md) | [(11.6%)](/filings/0000029332-24-000020.md) | [(1.0%)](/filings/0000029332-25-000017.md) | [(4.9%)](/filings/0000029332-26-000018.md) | [(3.0%)](/filings/0000029332-26-000018.md) | | Diluted EPS | $ per share | [0.09](/filings/0000029332-23-000015.md) | [(2.32)](/filings/0000029332-24-000020.md) | [(0.18)](/filings/0000029332-25-000017.md) | [(0.88)](/filings/0000029332-26-000018.md) | [(0.52)](/filings/0000029332-26-000018.md) | | Free cash flow | $m | [(11.0)](/filings/0000029332-23-000015.md) | [(22.1)](/filings/0000029332-24-000020.md) | [3.2](/filings/0000029332-25-000017.md) | [1.5](/filings/0000029332-26-000018.md) | [9.0](/filings/0000029332-26-000018.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dxyn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [HUNTINGTON NATIONAL BANK](/funds/49205.md) | 2026-06-30 | $0 | 1 | | Unchanged | ## Recent filings [All 863 filings](/companies/dxyn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 14:20 ET | [10-Q](/filings/0000029332-26-000045.md) | Quarterly report, period 2026-06-27 | 0000029332-26-000045 | | 2026-08-06 | 07:31 ET | [8-K](/filings/0000029332-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000029332-26-000043 | | 2026-08-06 | 07:23 ET | [8-K](/filings/0000029332-26-000041.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000029332-26-000041 | | 2026-05-26 | 15:07 ET | [SCHEDULE 13D](/filings/0000949130-26-000014.md) | Ownership report, active investor | 0000949130-26-000014 | | 2026-05-11 | 16:08 ET | [10-Q](/filings/0000029332-26-000031.md) | Quarterly report, period 2026-03-28 | 0000029332-26-000031 | | 2026-05-11 | 07:11 ET | [8-K](/filings/0000029332-26-000029.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000029332-26-000029 | | 2026-05-11 | 07:07 ET | [8-K](/filings/0000029332-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000029332-26-000027 | | 2026-05-07 | 11:57 ET | [8-K](/filings/0000029332-26-000023.md) | 5.07 Shareholder vote results | 0000029332-26-000023 | | 2026-03-26 | 14:51 ET | [DEF 14A](/filings/0000029332-26-000020.md) | Proxy statement, period 2026-03-26 | 0000029332-26-000020 | | 2026-03-26 | 14:47 ET | [10-K](/filings/0000029332-26-000018.md) | Annual report, period 2025-12-27 | 0000029332-26-000018 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 27, 2025](/filings/0000029332-26-000018.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e50573d2-a215-42b1-bbf9-42bb654b6e73) ## About the filer - CIK: 29332 - Tickers: DXYN - Exchange: OTC - SIC code: 2273 Carpets & Rugs - State of incorporation: TN - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.